Trial Profile
A Retrospective,Multicenter,Observational study to evaluate the efficacy and safety of Lenalidomide in patients with Myelodysplastic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 26 Oct 2016 New trial record